These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 1712246)

  • 1. Pharmacokinetics of recombinant human granulocyte colony-stimulating factor conjugated to polyethylene glycol in rats.
    Tanaka H; Satake-Ishikawa R; Ishikawa M; Matsuki S; Asano K
    Cancer Res; 1991 Jul; 51(14):3710-4. PubMed ID: 1712246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics and pharmacodynamics of recombinant human granulocyte-colony stimulating factor after intravenous and subcutaneous administration in the rat.
    Tanaka H; Okada Y; Kawagishi M; Tokiwa T
    J Pharmacol Exp Ther; 1989 Dec; 251(3):1199-203. PubMed ID: 2481032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of recombinant human granulocyte colony-stimulating factor studied in the rat by a sandwich enzyme-linked immunosorbent assay.
    Tanaka H; Tokiwa T
    J Pharmacol Exp Ther; 1990 Nov; 255(2):724-9. PubMed ID: 1700818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of recombinant human granulocyte colony-stimulating factor in the rat. Single and multiple dosing studies.
    Tanaka H; Kaneko T
    Drug Metab Dispos; 1991; 19(1):200-4. PubMed ID: 1708329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extended activity in cynomolgus monkeys of a granulocyte colony-stimulating factor mutein conjugated with high molecular weight polyethylene glycol.
    Eliason JF; Greway A; Tare N; Inoue T; Bowen S; Dar M; Yamasaki M; Okabe M; Horii I
    Stem Cells; 2000; 18(1):40-5. PubMed ID: 10661570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sex differences in the pharmacokinetics of recombinant human granulocyte colony-stimulating factor in the rat.
    Tanaka H; Kaneko T
    Drug Metab Dispos; 1991; 19(6):1034-9. PubMed ID: 1724959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of renal and hepatic failure on the pharmacokinetics of recombinant human granulocyte colony-stimulating factor (KRN8601) in the rat.
    Tanaka H; Tokiwa T
    Cancer Res; 1990 Oct; 50(20):6615-9. PubMed ID: 1698539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergistic effects of pegylated recombinant human megakaryocyte growth and development factor and granulocyte colony-stimulating factor on mobilization of hematopoietic progenitor and stem cells with long-term repopulating ability into peripheral blood in mice.
    Honda K; Takenaka K; Shinagawa K; Ishimaru F; Ikeda K; Niiya K; Harada M
    Bone Marrow Transplant; 2001 Aug; 28(4):329-34. PubMed ID: 11571503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum levels of endogenous and exogenous granulocyte colony-stimulating factor after autologous blood stem cell transplantation.
    Shimazaki C; Uchiyama H; Fujita N; Araki S; Sudo Y; Yamagata N; Ashihara E; Goto H; Inaba T; Haruyama H
    Exp Hematol; 1995 Dec; 23(14):1497-502. PubMed ID: 8542937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of recombinant human granulocyte colony-stimulating factor on hematopoiesis in normal cats.
    Fulton R; Gasper PW; Ogilvie GK; Boone TC; Dornsife RE
    Exp Hematol; 1991 Sep; 19(8):759-67. PubMed ID: 1714401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics and Pharmacodynamics of Two Formulations of Pegylated Recombinant Human Granulocyte Colony-Stimulating Factor in Healthy Chinese Subjects: An Open-Label, Randomized, Parallel-Design Bioavailability Study.
    Hu C; Ji B; Hu X; Yang C; Sun W; Zhao X; Li L; Li X; Zhang L
    Clin Pharmacol Drug Dev; 2021 Mar; 10(3):291-298. PubMed ID: 32567217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experimental study on safety for granulopoiesis in simultaneous therapy with recombinant human granulocyte colony-stimulating factor and chemotherapy.
    Kabaya K; Obuchi M; Watanabe M; Kusaka M; Seki M
    Oncol Res; 1995; 7(3-4):165-71. PubMed ID: 8555650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic and pharmacodynamic comparisons between human granulocyte colony-stimulating factor purified from human bladder carcinoma cell line 5637 culture medium and recombinant human granulocyte colony-stimulating factor produced in Escherichia coli.
    Tanaka H; Kaneko T
    J Pharmacol Exp Ther; 1992 Jul; 262(1):439-44. PubMed ID: 1625212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Three types of recombinant human granulocyte colony-stimulating factor have equivalent biological activities in monkeys.
    Tanaka H; Tanaka Y; Shinagawa K; Yamagishi Y; Ohtaki K; Asano K
    Cytokine; 1997 May; 9(5):360-9. PubMed ID: 9195136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo effects of recombinant human granulocyte colony-stimulating factor on normal neutrophil function and membrane effector molecule expression.
    Itoh Y; Kuratsuji T; Tsunawaki S; Aizawa S; Toyama K
    Int J Hematol; 1991 Dec; 54(6):463-9. PubMed ID: 1724390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of divalent polyethylene glycol units, conjugated on human granulocyte colony-stimulating factor, on biological activities in vitro and in vivo.
    Yamasaki M; Asano M; Yokoo Y; Okabe M
    Drugs Exp Clin Res; 1998; 24(4):191-6. PubMed ID: 10051965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A synergistic increase in transplantable peripheral blood stem cells in mice by co-administration of recombinant human interleukin 6 and recombinant human granulocyte colony-stimulating factor.
    Suzuki H; Okano A; Suzuki C; Konishi A; Akiyama Y; Ishibashi T; Ozawa K; Asano S
    Transplantation; 1995 Jun; 59(11):1596-600. PubMed ID: 7539959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of recombinant human granulocyte colony-stimulating factor (rhG-CSF) on allogeneic bone marrow transplantation in mice.
    Fukuhara N; Ohnishi N; Mori T; Ozawa A
    Tokai J Exp Clin Med; 1990 May; 15(2-3):261-2. PubMed ID: 1718058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized controlled clinical trial of polyethylene glycol recombinant human granulocyte colony-stimulating factor in the treatment of neutropenia after chemotherapy for breast cancer.
    Huang W; Liu J; Zeng Y; Wu F; Li N; Chen K; Hong Y; Wang L; Zhen H; Lin L
    Cancer Chemother Pharmacol; 2018 Oct; 82(4):607-613. PubMed ID: 30043207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The effects and pharmacokinetics of rhG-CSF on the treatment of neutropenia in patients with renal failure].
    Shishido K; Niikura K; Akizawa T; Koshikawa S
    Nihon Jinzo Gakkai Shi; 1991 Oct; 33(10):973-81. PubMed ID: 1722829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.